-
PurposeCre-conditionally expresses the anti-GFP Nanobody-Rpl10a fusion
-
Depositing Lab
-
Sequence Information
-
Sequences (3) — Accept Affinity Reagent Sequence Policy
-
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 69971 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA
-
Backbone manufacturerKarl Deisseroth
- Backbone size w/o insert (bp) 5600
- Total vector size (bp) 6672
-
Modifications to backbonen/a
-
Vector typeMammalian Expression, AAV, Cre/Lox
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)Stbl3
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameNBL10
-
Alt nameNanobody-L10
-
Alt nameAnti-GFP Nanobody-Rpl10a
-
SpeciesM. musculus (mouse); Lama pacos (camelid)
-
Insert Size (bp)1038
- Promoter EF1a
-
Tag
/ Fusion Protein
- HA (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site AscI (not destroyed)
- 3′ cloning site NheI (not destroyed)
- 5′ sequencing primer oME328
- 3′ sequencing primer oME327 (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byNanobody from Rothbauer et al., 2006; L10 from Heiman et al., 2008
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
See also Nectow et al., Nature Protocols (2015).
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pAAV-FLEX-NBL10 was a gift from Jeffrey Friedman (Addgene plasmid # 69971 ; http://n2t.net/addgene:69971 ; RRID:Addgene_69971) -
For your References section:
Molecular profiling of neurons based on connectivity. Ekstrand MI, Nectow AR, Knight ZA, Latcha KN, Pomeranz LE, Friedman JM. Cell. 2014 May 22;157(5):1230-42. doi: 10.1016/j.cell.2014.03.059. 10.1016/j.cell.2014.03.059 PubMed 24855954